As of May 2024 Glaukos has a market cap of $5.61 Billion. This makes Glaukos the world's 2497th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $5.61 B | 44.63% |
2023 | $3.87 B | 86.16% |
2022 | $2.08 B | -0.01% |
2021 | $2.08 B | -38.42% |
2020 | $3.38 B | 42.8% |
2019 | $2.36 B | 16.83% |
2018 | $2.02 B | 128.75% |
2017 | $0.88 B | -22.95% |
2016 | $1.15 B | 44.83% |
2015 | $0.79 B |
On May 14th, 2024 the market cap of Glaukos was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ICU Medical
ICUI | $2.62 B | -53.28% | ๐บ๐ธ USA |
AtriCure ATRC | $1.09 B | -80.42% | ๐บ๐ธ USA |
Integra LifeSciences IART | $2.08 B | -62.82% | ๐บ๐ธ USA |
Hill-Rom HRC | $10.30 B | 83.61% | ๐บ๐ธ USA |